Replies to post #248 on TScan Therapeutics Inc (TCRX)

[jondoeuk]

Upcoming at ASCO https://finance.yahoo.com/news/tscan-therapeutics-announces-upcoming-presentations-200500617.html

Initial data from a phase 1, first-in-human clinical trial for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy (TCR-T) for solid tumors https://meetings.asco.org/abstracts-presentations/233898

A phase 1 trial of TSC-100 and TSC-101, engineered T cell therapies that target minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation https://meetings.asco.org/abstracts-presentations/238322

The majority of abstracts will be released on the 23rd, at 5:00 PM (ET).